Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > What is the Time Line for some Cancer Free News
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1035)
•••
Comment by enriquesuaveon Jun 06, 2021 8:20am
179 Views
Post# 33337136

RE:RE:RE:RE:RE:What is the Time Line for some Cancer Free News

RE:RE:RE:RE:RE:What is the Time Line for some Cancer Free News

There might be an error in the number of patients having received an optimized treatment?  That would be be 7 from 1st set of 12 and 4 from next set?


enriquesuave wrote: It will be quite clear pretty soon. IMO  when we see 6 and 9 months data(3 months post maintenance treatment)

"To date, 7 patients have received the optimized Primary Study Treatment and 11 patients have received the optimized Maintenance Study Treatment in Study II.
A preliminary analysis of the primary objective at 90 days for patients receiving the optimized primary Study Treatment demonstrates a 28.6% CR rate, with 57.1% data pending and 14.3% with no response"


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities